Show simple item record

dc.contributor.authorWooley, Paul H.
dc.contributor.authorSong, Zheng
dc.contributor.authorHarrison, Andrew
dc.date.accessioned2013-07-18T19:00:52Z
dc.date.available2013-07-18T19:00:52Z
dc.date.issued2012-04
dc.identifier.citationWooley PH, Song Z, Harrison A. 2012. Hyaluronic acid viscosupplements from avian and non-mammalian sources exhibit biocompatibility profiles with unique, source-specific, antigenic profiles. J Biomed Mater Res Part B 2012:100B:808–816. doi: 10.1002/jbm.b.32514en_US
dc.identifier.issn1552-4973 (Print)
dc.identifier.issn1552-4981 (Electronic)
dc.identifier.urihttp://hdl.handle.net/10057/5988
dc.descriptionClick on the DOI link to access this articleen_US
dc.description.abstractThe objective of this study was to evaluate and compare the biocompatibility profiles of hyaluronic acid (HA) viscosupplements from avian and non-mammalian sources. Inflammatory and immune reactions were assessed in models of both clinically relevant and stringent immunological exposure conditions. Experiments were conducted to evaluate tissue reactions and immunological responses and assess antibody formation with the capacity to bind directly to and cross-react with the different viscosupplements. Mice were exposed to viscosupplements using the air pouch inflammation model and specific immunization using Freund’s complete adjuvant (FCA). Murine pouch membrane tissue reactions revealed generally mild to moderate responses, with cellular infiltration and cytokine profiles of pouch tissue characteristic of predominantly fibroblastic responses rather than marked inflammatory reactions. In vitro testing indicated that pouch injections did not elicit detectable T-cell proliferative responses, while antibody assays revealed that mice immunized with viscosupplements in FCA and subsequently boosted were capable of mounting an antibody response with a range of specificities. High reactivity to avian serum albumin was seen in sera from mice injected with HA from an avian source, while low positive reactivity to the bacterial antigen Staphylococcal Lipotechoic Acid was observed in sera from mice injected with HA from bacterial sources. These specificities did not indicate any propensity to cross-react, suggesting that patients with adverse immune responses to HA from an avian source should be unresponsive to subsequent injection with HA from a non-avian source. Overall, the findings demonstrate that viscosupplements exhibit good biocompatibility profiles in the murine air pouch, but when provoked to elicit immunological reactions exhibit unique antigenic spectra. These findings suggest that an immunologically mediated immune reaction directed against avian proteins should not necessarily be a contraindication for the administration of non-avian viscosupplements.en_US
dc.language.isoen_USen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.relation.ispartofseriesJournal of Biomedical Materials Research Part B: Applied Biomaterials;
dc.relation.ispartofseries;V.100B, No.3
dc.subjectBiocompatibility/soft tissueen_US
dc.subjectBiological fluidsen_US
dc.subjectCytotoxicityen_US
dc.subjectImmune responseen_US
dc.subjectIn vivoen_US
dc.titleHyaluronic acid viscosupplements from avian and non-mammalian sources exhibit biocompatibility profiles with unique, source-specific, antigenic profilesen_US
dc.typeArticleen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record